Simon M. Shubitz Cancer Prize and Lectureship
Since 1978, the Simon M. Shubitz Cancer Prize and Lectureship has recognized excellence in cancer research and brought to the University of Chicago internationally respected scientists who have made significant contributions to the study of cancer. The award is named in honor of Simon M. Shubitz, MD, a distinguished alumnus known for his dedication as a physician and his efforts as a humanitarian and philanthropist.
While originally presented biannually, the Comprehensive Cancer Center and the University of Chicago Cancer Research Foundation now present the award annually.
“The truly great physician is the one who meticulously searches, teaches, and heals. That ideal physician is the true Laureate of Medicine from whom we can learn, and whose presence will inspire us all.”
– Simon M. Shubitz, MD
2020 Shubitz Award Recipient
Otis W. Brawley, SB’81, MD’85 is the Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University, the former chief medical and scientific officer of the American Cancer Society and a world-renowned cancer expert working to close racial, economic and social disparities in the prevention, detection and treatment of cancer.
Brawley’s research focuses on developing cancer screening strategies and ensuring their effectiveness. He has championed efforts to decrease smoking and implement other lifestyle risk reduction programs, as well as to provide critical support to cancer patients and concentrate cancer control efforts in areas where they could be most effective. Brawley currently leads a broad interdisciplinary research effort on cancer health disparities at the Bloomberg School of Public Health and the Johns Hopkins Kimmel Cancer Center, striving to close racial, economic, and social disparities in the prevention, detection, and treatment of cancer in the United States and worldwide. He also directs community outreach programs for underserved populations throughout Maryland.
- Past Recipients
2020 – Richard Pazdur, MD, director of the US Food and Drug Administration’s Oncology Center of Excellence
2019 – Laura Esserman, MD, MBA, University of California, San Francisco (UCSF)
2018 – Michael Caliguiri, MD, City of Hope, Duarte, California
2017 – Arul M. Chinnaiyan, MD, PhD, University of Michigan
2016 – James R. Downing, MD, St. Jude Children’s Research Hospital, Memphis, Tennessee
2015 – Lewis C. Cantley, PhD, Meyer Cancer Center, New York
2014 – Nancy Davidson, MD, University of Pittsburgh Cancer Institute and UPMC Cancer Center
2013 – Todd Golub, MD, Dana-Farber Cancer Institute, Boston, Mass.
2012 – Joe Gray, PhD, Oregon Health & Science University, Knight Cancer Institute, Portland
2011 – Charles L. Sawyers, MD, Memorial Sloan-Kettering Cancer Center, New York
2010 – Irving L. Weissman, MD, Stanford University, Palo Alto, Calif.
2009 – Margaret R. Spitz, MD, MPH, The University of Texas MD Anderson Cancer Center, Houston
2008 – Brian J. Druker, MD, Oregon Health and Science University, Portland
2007 – Craig B. Thompson, MD, Abramson Cancer Center of the University of Pennsylvania, Philadelphia
2006 – Tyler E. Jacks, PhD, Howard Hughes Medical Institute, Cambridge, Mass.
2005 – Stephen B. Baylin, MD, The Johns Hopkins University School of Medicine, Baltimore, Md.
2004 – Ronald M. Evans, PhD, Howard Hughes Medical Institute, La Jolla, Calif.
2003 – Frank McCormick, PhD, FRS. University of California, San Francisco
2002 – John Mendelsohn, MD, The University of Texas, Houston
2001 – Peter A. Jones, PhD, University of Southern California, Los Angeles
2000 – Alexander Varshavsky, PhD, California Institute of Technology, Pasadena
1999 – Mary Claire King, MD, University of Washington, Seattle
1998 – Albert de la Chapelle, MD, PhD, The Ohio State University, Columbus
1997 – Stanley J. Korsmeyer, MD, Washington University, Saint Louis
1996 – Elizabeth H. Blackburn, PhD, University of California, San Francisco
1995 – Arnold J. Levine, PhD, Princeton University, N.J.
1994 – Raymond L. White, PhD, University of Utah, Salt Lake City
1993 – Michael B. Sporn, MD, National Cancer Institute, Bethesda, Md.
1992 – Leland H. Hartwell, PhD, University of Washington, Seattle
1991 – Lance A. Liotta, MD, PhD, National Cancer Institute, Bethesda, Md.
1990 – Robert T. Schimke, MD, Stanford University, Calif.
1989 – Robert A. Weinberg, PhD, Massachusetts Institute of Technology, Cambridge
1988 – Steven Rosenberg, MD, PhD, National Cancer Institute, Bethesda, Md.
1987 – Thomas A. Waldmann, MD, National Cancer Institute, Bethesda, Md.
1986 – Philip Leder, MD, Harvard Medical School, Boston
1985 – Robert C. Gallo, MD, National Cancer Institute, Bethesda, Md.
1984 – Harold E. Varmus, MD, University of California, San Francisco
1982 – Judah Folkman, MD, Harvard Medical School, Boston
1980 – Peter C. Nowell, MD, University of Pennsylvania, Philadelphia
1978 – Bruce N. Ames, PhD, University of California, Berkeley